769 related articles for article (PubMed ID: 12734136)
1. Effect of a national disaster on blood supply and safety: the September 11 experience.
Glynn SA; Busch MP; Schreiber GB; Murphy EL; Wright DJ; Tu Y; Kleinman SH;
JAMA; 2003 May; 289(17):2246-53. PubMed ID: 12734136
[TBL] [Abstract][Full Text] [Related]
2. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).
Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE
JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598
[TBL] [Abstract][Full Text] [Related]
3. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan.
Moiz B; Moatter T; Shaikh U; Adil S; Ali N; Mahar F; Shamsuddin N; Khurshid M
Transfusion; 2014 Jun; 54(6):1652-9. PubMed ID: 24383918
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa.
Heyns Adu P; Benjamin RJ; Swanevelder JP; Laycock ME; Pappalardo BL; Crookes RL; Wright DJ; Busch MP
JAMA; 2006 Feb; 295(5):519-26. PubMed ID: 16449617
[TBL] [Abstract][Full Text] [Related]
5. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
[TBL] [Abstract][Full Text] [Related]
6. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H;
Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978
[TBL] [Abstract][Full Text] [Related]
7. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
8. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.
Whyte GS; Savoia HF
Med J Aust; 1997 Jun; 166(11):584-6. PubMed ID: 9201178
[TBL] [Abstract][Full Text] [Related]
9. First-time donors responding to a national disaster may be an untapped resource for the blood centre.
Guo N; Wang J; Ness P; Yao F; Bi X; Li J; Yun Z; Guo X; Huang Y; Dong X; Tiemuer MH; He W; Ma H; Huang M; Liu J; Wright DJ; Nelson K; Shan H;
Vox Sang; 2012 May; 102(4):338-44. PubMed ID: 21988212
[TBL] [Abstract][Full Text] [Related]
10. A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010.
Dorsey KA; Moritz ED; Steele WR; Eder AF; Stramer SL
Transfusion; 2013 Jun; 53(6):1250-6. PubMed ID: 23003320
[TBL] [Abstract][Full Text] [Related]
11. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
[TBL] [Abstract][Full Text] [Related]
12. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Fearon MA; Allain JP
Vox Sang; 2012 Jul; 103(1):83-6. PubMed ID: 22289147
[TBL] [Abstract][Full Text] [Related]
13. Demographic determinants of hepatitis C virus seroprevalence among blood donors.
Murphy EL; Bryzman S; Williams AE; Co-Chien H; Schreiber GB; Ownby HE; Gilcher RO; Kleinman SH; Matijas L; Thomson RA; Nemo GJ
JAMA; 1996 Apr; 275(13):995-1000. PubMed ID: 8596257
[TBL] [Abstract][Full Text] [Related]
14. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
Hitzler WE
Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
[TBL] [Abstract][Full Text] [Related]
15. Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations.
Zou S; Stramer SL; Dodd RY
Transfus Med Rev; 2012 Apr; 26(2):119-28. PubMed ID: 21871776
[TBL] [Abstract][Full Text] [Related]
16. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.
Soldan K; Barbara JA; Ramsay ME; Hall AJ
Vox Sang; 2003 May; 84(4):274-86. PubMed ID: 12757501
[TBL] [Abstract][Full Text] [Related]
17. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
18. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
Shang G; Seed CR; Wang F; Nie D; Farrugia A
Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836
[TBL] [Abstract][Full Text] [Related]
19. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study.
Williams AE; Thomson RA; Schreiber GB; Watanabe K; Bethel J; Lo A; Kleinman SH; Hollingsworth CG; Nemo GJ
JAMA; 1997 Mar; 277(12):967-72. PubMed ID: 9091668
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
Roth WK; Weber M; Seifried E
Lancet; 1999 Jan; 353(9150):359-63. PubMed ID: 9950441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
